Elbit Imaging-M Ltd. — Regulatory Filings 2011

Jun 6, 2011

==> picture [424 x 76] intentionally omitted <==

ELBIT IMAGING LTD. BOARD OF DIRECTORS RESOLVES NOT TO DIRSTRIBUTE DIVIDENDS IN UPCOMING YEAR

Tel Aviv, Israel, June 6, 2011, Elbit Imaging Ltd. (“Elbit”) (NASDAQ: EMITF) announced today that the Board of Directors of Elbit has resolved not to distribute any dividends for at least the next 12 months. At the end of the abovementioned 12-month period the Board of Directors will evaluate whether to extend such policy.

Mr. Shimon Yizhaki, the Chairman of the Board of Directors of Elbit, commented: “The Board wants to ensure Elbit’s strength and to preserve its liquidity in the face of the current volatility in the Company's securities in the recent days. We are confident that such responsible actions will be beneficial for the Company in the long run”.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India; (ii) U.S. Real Property - Investment in commercial real property in the United States; (iii) Hotels - Hotel operation and management, primarily in major European cities; (iv) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (v) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India and in Eastern Europe; (vi) Fashion Apparel - distribution and marketing of fashion apparel and accessories in Israel; and (vii) Other Activities - (a) venture capital investments; and (b) investments in hospitals and farm and dairy plants in India.

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as “believe,” “expect,” “intend,” “estimate” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2009, under the caption “Risk Factors.” Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forwardlooking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forwardlooking statements.

For Further Information:

Company Contact: Dudi Machluf Chief Executive Officer (Co-CEO) Tel: +972-3-608-6024 dudim@elbitimaging.com

Investor Contact: Mor Dagan Investor Relations Tel: +972-3-516-7620 mor@km-ir.co.il

Elbit Imaging Ltd. 2 Weitzman Street, Tel Aviv 64239, Israel Tel: +972-3-608-6000 Fax: +972-3-608-6054